1. Home
  2. ALLO vs WTI Comparison

ALLO vs WTI Comparison

Compare ALLO & WTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • WTI
  • Stock Information
  • Founded
  • ALLO 2017
  • WTI 1983
  • Country
  • ALLO United States
  • WTI United States
  • Employees
  • ALLO N/A
  • WTI N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • WTI Oil & Gas Production
  • Sector
  • ALLO Health Care
  • WTI Energy
  • Exchange
  • ALLO Nasdaq
  • WTI Nasdaq
  • Market Cap
  • ALLO 252.9M
  • WTI 259.9M
  • IPO Year
  • ALLO 2018
  • WTI 2005
  • Fundamental
  • Price
  • ALLO $1.13
  • WTI $1.82
  • Analyst Decision
  • ALLO Strong Buy
  • WTI
  • Analyst Count
  • ALLO 10
  • WTI 0
  • Target Price
  • ALLO $8.88
  • WTI N/A
  • AVG Volume (30 Days)
  • ALLO 3.0M
  • WTI 859.0K
  • Earning Date
  • ALLO 11-06-2025
  • WTI 11-06-2025
  • Dividend Yield
  • ALLO N/A
  • WTI 2.21%
  • EPS Growth
  • ALLO N/A
  • WTI N/A
  • EPS
  • ALLO N/A
  • WTI N/A
  • Revenue
  • ALLO N/A
  • WTI $493,951,000.00
  • Revenue This Year
  • ALLO N/A
  • WTI $2.41
  • Revenue Next Year
  • ALLO $100.00
  • WTI $5.96
  • P/E Ratio
  • ALLO N/A
  • WTI N/A
  • Revenue Growth
  • ALLO N/A
  • WTI N/A
  • 52 Week Low
  • ALLO $0.86
  • WTI $1.09
  • 52 Week High
  • ALLO $3.78
  • WTI $2.84
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 47.86
  • WTI 55.43
  • Support Level
  • ALLO $1.09
  • WTI $1.72
  • Resistance Level
  • ALLO $1.21
  • WTI $1.77
  • Average True Range (ATR)
  • ALLO 0.07
  • WTI 0.06
  • MACD
  • ALLO 0.01
  • WTI 0.00
  • Stochastic Oscillator
  • ALLO 33.33
  • WTI 70.00

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About WTI W&T Offshore Inc.

W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.

Share on Social Networks: